Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Girolomoni, Giampiero;
2022-01-01
Abstract
Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Chiricozzi Dermatitis 2022.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
147.04 kB
Formato
Adobe PDF
|
147.04 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
